期刊文献+

病毒样颗粒疫苗的研究及其在动物疫病防控中的应用前景

下载PDF
导出
摘要 疫苗是人类预防疾病,尤其是传染性疾病最行之有效的工具。自消灭了天花的牛痘疫苗问世后,200多年间疫苗家族不断发展壮大,如今已经发展到第三代疫苗。目前,一种属于第二代疫苗家族的新型疫苗——病毒样颗粒疫苗(viruslikeparticles,VLP)因其独有的结构和高效性、安全性得到了人们的重视,有望成为动物疫病防控的利器,本文就VLP的研究进展进行综述。
作者 毛凝
出处 《农业开发与装备》 2013年第1期38-39,共2页 Agricultural Development & Equipments
  • 相关文献

参考文献17

  • 1吴蒙,张定梅,陆家海.流感病毒样颗粒疫苗研究进展[J].中山大学学报(医学科学版),2009,30(5):486-491. 被引量:4
  • 2王亚君,华育平.病毒样颗粒疫苗的研究进展[J].黑龙江畜牧兽医,2008(8):25-26. 被引量:9
  • 3司菡,曲新勇(综述),陆家海(审校).病毒样颗粒疫苗的研究进展[J].中国人兽共患病学报,2008,24(1):80-82. 被引量:6
  • 4Fausch SC,Da SilvadM,Kast WM. Difierential uptake and cross-presentation ofhuman papillomavirus virus-like particles bydendritic cells and Langerhans cells[J].{H}CANCER RESEARCH,2003,(13):3478-3482.
  • 5Rudolfm P,Fausch SC,DaSilvad M,et a1. Humandendritic cells are activated by chimerichuman papillomavirustype-16 virus-like panicles and induce epitope-specifichumant cell responses in vitro[J].{H}Journal of Immunology,2001,(10):5917-5924.
  • 6Da SilvadM,PastranadV,Schiller JT,et a1. Effect of preexisting neutralizing antibodies onthe anti-tumor immune response induced by chimerichuman papillomavirus virus-like particle vaccines[J].{H}VIROLOGY,2001,(02):350-360.
  • 7WarrinodE,Olson WC,ScarrowmI,et a1. Human papillomavirus L1L2@-E7 virus@-like panicles partiallymaturehumandendritic cells and elicit E7-specifict--helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitro[J].{H}Human Immunology,2005,(07):762-772.
  • 8Keim B. Controversy over cervical cancer vaccine spurs safety surveillance[J].{H}Nature Medicine,2007,(04):392-393.
  • 9朱珊丽,张丽芳.病毒样颗粒疫苗的应用前景[J].国外医学(预防.诊断.治疗用生物制品分册),2004,27(5):193-196. 被引量:2
  • 10刘跃华,刘晓松,IanH.Frazer.人乳头瘤病毒6b型病毒样颗粒免疫活性的研究[J].中华医学杂志,2002,82(9):587-589. 被引量:7

二级参考文献113

  • 1Grgacic EV,Anderson DA.Virus-like particles:passport to immune recognition[J].Methods,2006,40(1):60-65.
  • 2Keim B.Controversy over cervical cancer vaccine spurs safety surveillance[J].Nat Med,2007,13 (4):392-393.
  • 3Scheiffele P,Rietveld A,Wilk T,et al.Influenza viruses select ordered lipid domains during budding from the plasma membrane[J].J Biol Chem,1999,274 (4):2038-2044.
  • 4Latham T,Galarza JM.Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins[J].J Virol,2001,75(13):6154-6165.
  • 5Gomez-Puertas P,Albo C,Perez-Pastrana E,et al.Influenza virus matrix protein is the major driving force in virus budding[J].J Virol,2000,74(24):11538-11547.
  • 6Watanabe T,Watanabe S,Neumann G,et al.Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles[J].J Virol,2002,76 (2):767-773.
  • 7Ali A,Avalos RT,Ponimaskin E,et al.Influenza virus assembly:effect of influenza virus glycoproteins on the membrane association of M1 protein[J].J Virol,2000,74(18):8709-8719.
  • 8Chen B J,Leser GP,Morita E,et al.Influenza virus hemagglutinin and neuraminidase,but not the matrix protein,are required for assembly and budding of plasmid-derived virus-like particles[J].J Virol,2007,81(13):7111-7123.
  • 9Szecsi J,Boson B,Johnsson P,et al.Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses[J].Virol J,2006,3 (1):70-75.
  • 10Quan FS,Steinhauer D,Huang C,et al.A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs[J].Vaccine,2008,26(26):3352-3361.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部